Long-Term Survival in BRCA1 Mutant Advanced Ovarian Cancer: Unveiling the Impact of Olaparib

Long-Term Survival in BRCA1 Mutant Advanced Ovarian Cancer: Unveiling the Impact of Olaparib

Ovarian cancer is one of the most frequent malignancies in women. The treatment landscape underwent significant changes as new agents were introduced in ovarian cancer management over the last decade. We present two cases of long responses to Olaparib in BRCA (BReast CAncer gene) mutant ovarian canc...

Full description

Bibliographic Details
Main Authors: Vlad-Adrian Afrăsânie, Alexandra Rusu, Adelina Silvana Gheorghe, Eliza Maria Froicu, Elena Adriana Dumitrescu, Bogdan Gafton, Teodora Alexa-Stratulat, Lucian Miron, Dana Lucia Stănculeanu, Mihai Vasile Marinca
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Diagnostics
Subjects:
BRCA1 mutation
ovarian cancer
Olaparib
chemotherapy
Online Access:https://www.mdpi.com/2075-4418/14/17/1898

Internet

https://www.mdpi.com/2075-4418/14/17/1898

Similar Items